We are live on ! Find out more
VIGL

Vigil Neuroscience
VIGL

Delisted

VIGL was delisted on the 4th of August, 2025.

Back to rankings

47 hedge funds and large institutions have $242M invested in Vigil Neuroscience in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 7

50% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 8

18% more funds holding

Funds holding: 40 → 47 (+7)

1.85% more ownership

Funds ownership: 70.3% → 72.15% (+1.9%)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

2% less capital invested

Capital invested by funds: $246M → $242M (-$3.95M)

Holders
47
Holders Change
+7
Holders Change %
+17.5%
% of All Funds
0.74%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
15
Increased
12
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.8M
2
State Street
State Street
Massachusetts
+$2.12M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.63M
4
Northern Trust
Northern Trust
Illinois
+$966K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$602K

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$3.14M
2
DTC
Deep Track Capital
Connecticut
-$2.38M
3
Millennium Management
Millennium Management
New York
-$699K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$575K
5
Morgan Stanley
Morgan Stanley
New York
-$404K
Name Holding Trade Value Shares
Change 		Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$54.9M – – –
NV
2
Northpond Ventures
Maryland
$39.6M – – –
Citadel Advisors
3
Citadel Advisors
Florida
$20.5M +$175K +18,528 +0.9%
DM
4
Deerfield Management
New York
$19.3M – – –
AG
5
Artal Group
Luxembourg
$18M -$3.14M -332,161 -15%
BI
6
BVF Inc
California
$17M – – –
DTC
7
Deep Track Capital
Connecticut
$16.7M -$2.38M -251,728 -12%
BlackRock
8
BlackRock
New York
$7.72M +$6.8M +719,366 +705%
Vanguard Group
9
Vanguard Group
Pennsylvania
$7.45M +$602K +63,623 +9%
CAM
10
Cormorant Asset Management
Massachusetts
$5.8M – – –
PBPIA
11
Pivotal bioVenture Partners Investment Advisor
California
$5.27M – – –
RSCM
12
Rock Springs Capital Management
Maryland
$4.44M – – –
O
13
OrbiMed
New York
$4.22M – – –
HMC
14
Harvard Management Company
Massachusetts
$2.72M – – –
Geode Capital Management
15
Geode Capital Management
Massachusetts
$2.68M +$1.63M +172,451 +153%
State Street
16
State Street
Massachusetts
$2.44M +$2.12M +223,960 +627%
TOCUITCONY
17
Trustees of Columbia University in the City of New York
New York
$1.81M – – –
LGM
18
Logos Global Management
California
$1.77M – – –
DCM
19
DAFNA Capital Management
California
$1.62M – – –
Fidelity Investments
20
Fidelity Investments
Massachusetts
$1.32M +$507K +53,676 +62%
Northern Trust
21
Northern Trust
Illinois
$1.17M +$966K +102,127 +459%
Barclays
22
Barclays
United Kingdom
$986K +$6.18K +654 +0.6%
LCM
23
Laurion Capital Management
New York
$937K -$288K -30,511 -23%
Bank of Montreal
24
Bank of Montreal
Ontario, Canada
$728K +$302K +31,950 +77%
Citigroup
25
Citigroup
New York
$649K -$211K -22,321 -24%
1
2 3

VIGL Hedge Fund Activity: Q2 2023 in Review

47 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in Vigil Neuroscience (VIGL) for Q2 2023, worth a combined $242M — down 1.6% from $246M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new VIGL positions and 7 closed out — a net gain of 8 holders — while 12 added to existing stakes and 8 trimmed.

The largest buyer was BlackRock, adding an estimated $6.8M. The largest seller was Artal Group, cutting an estimated $3.14M.

  • 47 institutional investors held Vigil Neuroscience (VIGL) as of Q2 2023, up from 40 in Q1 2023.
  • Funds reported $242M of Vigil Neuroscience stock for Q2 2023, down 1.6% quarter-over-quarter.
  • 15 funds opened new Vigil Neuroscience positions in Q2 2023 and 7 closed out, a net change of +8 holders.
  • The largest Vigil Neuroscience buyer in Q2 2023 was BlackRock, an estimated $6.8M added.
  • The largest Vigil Neuroscience seller in Q2 2023 was Artal Group, an estimated $3.14M sold.

Based on aggregated 13F filings for Q2 2023.